Treatment for Lyme Disease
For a patient diagnosed with Lyme disease, treat with oral doxycycline 100 mg twice daily for 14 days (10-21 day range acceptable), or alternatively amoxicillin 500 mg three times daily or cefuroxime axetil 500 mg twice daily for 14-21 days 1.
First-Line Oral Antibiotic Options
The IDSA guidelines establish three equally effective first-line agents for early Lyme disease 1:
- Doxycycline 100 mg twice daily - preferred option with additional coverage for human granulocytic anaplasmosis (HGA), which can co-occur with Lyme disease
- Amoxicillin 500 mg three times daily
- Cefuroxime axetil 500 mg twice daily
Treatment Duration
- Doxycycline: 10-21 days (10 days is sufficient based on randomized controlled trial data) 2
- Amoxicillin or cefuroxime: 14-21 days (14 days recommended for uniformity due to shorter half-life of beta-lactams) 1
A landmark randomized trial of 180 patients demonstrated that 10 days of doxycycline was equally effective as 20 days, with complete response rates exceeding 83% at 30 months 2. The addition of IV ceftriaxone to doxycycline provided no benefit and increased diarrhea 4-fold 1.
Special Populations
Children under 8 years: Use amoxicillin (50 mg/kg/day in 3 divided doses, max 500 mg/dose) or cefuroxime axetil (30 mg/kg/day in 2 divided doses, max 500 mg/dose) 1
Pregnant or lactating women: Treat identically to non-pregnant patients but avoid doxycycline; use amoxicillin or cefuroxime 1
Children ≥8 years: Doxycycline (4 mg/kg/day in 2 divided doses, max 100 mg/dose) is acceptable 1
When to Avoid or Use Alternative Agents
Macrolides are NOT first-line therapy due to inferior efficacy 1. Reserve azithromycin, clarithromycin, or erythromycin only for patients with documented intolerance to all three first-line agents (doxycycline, amoxicillin, cefuroxime). Patients on macrolides require close monitoring 1.
Never use: First-generation cephalosporins (e.g., cephalexin), fluoroquinolones, or benzathine penicillin G - these are ineffective 1.
When IV Therapy is Required
IV ceftriaxone is NOT indicated for uncomplicated early Lyme disease 1. Reserve parenteral therapy for:
- Neurologic involvement (meningitis, radiculopathy, encephalomyelitis)
- Advanced atrioventricular heart block
- Severe Lyme carditis requiring hospitalization 3
Monitoring for Coinfection
Consider coinfection with Babesia or Anaplasma if the patient has 1:
- High fever persisting >48 hours despite appropriate antibiotics
- Unexplained leukopenia, thrombocytopenia, or anemia
- More severe initial symptoms than typical for Lyme disease alone
- Worsening viral-like symptoms despite resolution of erythema migrans
Expected Response and Follow-Up
Most patients respond promptly and completely to treatment 1. Key points:
- Complete resolution may be delayed beyond treatment completion - this is normal
- <10% fail to respond to initial therapy based on objective findings 1
- Some patients have persistent subjective complaints (fatigue, pain) despite curative therapy - this does NOT indicate treatment failure 1
- Retreatment is rarely required and should only be considered with objective evidence of active disease 3, 4
Important Caveats
Doxycycline precautions: Take with 8 ounces of fluid to prevent esophageal irritation, take with food to reduce GI upset, and avoid sun exposure due to photosensitivity risk 1.
Do NOT use prolonged or repeated antibiotic courses for persistent subjective symptoms without objective findings - multiple studies show no benefit and risk of serious adverse events 3, 4. The 2020 IDSA/AAN/ACR guidelines strongly recommend against additional antibiotics for nonspecific symptoms following standard treatment 3.
Serology remains positive long-term after successful treatment and cannot distinguish cured from active infection 4. Do not retest serology to assess cure.